Consistent with these findings cotinine, a nootropic agent that modulates α7nAchR could be used as adjunctive therapy for PTSD (Table 1) and other neuropsychiatric conditions that cause neuroinflammation and dysfunction of learning and memory (Fig. 3) (Mendoza et al. 2018). The gene discussed is CHRNA7; the disease is post-traumatic stress disorder.